公开(公告)号：US20100221600A1

公开(公告)日：2010-09-02

申请号：US12086988

申请日：2007-01-05

申请人： Eiko Yasuhara ,  Nobuko Nakagawa ,  Reiko Sugihara ,  Tadashi Inoue

发明人： Eiko Yasuhara ,  Nobuko Nakagawa ,  Reiko Sugihara ,  Tadashi Inoue

IPC分类号： H01M2/02 ,  C21D8/02 ,  C22C38/00

CPC分类号： C21D9/46 ,  C21D8/0205 ,  C21D2211/005 ,  C22C38/004 ,  C22C38/04 ,  C22C38/18 ,  C22C38/38 ,  C23C2/02 ,  H01M2/0257 ,  H01M2/0285 ,  Y10T29/49108

摘要： A cold-rolled steel sheet having superior non-ageing properties and low planar anisotropy can be produced at low cost without decreased productivity. This cold-rolled steel sheet contains, by mass, 0.010% to 0.040% carbon, 0.02% or less silicon, 1.0% to 2.5% manganese, 0.02% or less phosphorus, 0.015% or less sulfur, 0.004% or less nitrogen, and 0.020% to 0.070% aluminum, the balance being iron and incidental impurities. The steel sheet has a microstructure including a ferrite phase and a second phase. The volume percentage of the second phase is 0.2% to less than 10%. The steel sheet has an AI of 50 MPa or less, −0.20≦Δr≦0.20, and a thickness of 0.5 mm or less.

摘要翻译： 可以低成本地制造具有优异的非时效性和低平面各向异性的冷轧钢板，而不降低生产率。 该冷轧钢板以质量计含有0.010〜0.040％的碳，0.02％以下的硅，1.0〜2.5％的锰，0.02％以下的磷，0.015％以下的硫，0.004％以下的氮，以及 0.020％至0.070％的铝，余量为铁和杂质。 钢板具有包括铁素体相和第二相的微结构。 第二相的体积百分比为0.2％至小于10％。 钢板的AI为50MPa以下，-0.20＆lt; lE;＆Dgr; r＆nlE; 0.20，厚度为0.5mm以下。

公开(公告)号：US08388770B2

公开(公告)日：2013-03-05

申请号：US12282538

申请日：2007-03-13

申请人： Nobuko Mineji ,  Eiko Yasuhara ,  Reiko Sugihara ,  Tadashi Inoue

发明人： Nobuko Mineji ,  Eiko Yasuhara ,  Reiko Sugihara ,  Tadashi Inoue

IPC分类号： C22C38/00 ,  C22C38/14

CPC分类号： B21B1/22 ,  B21B3/00 ,  C21D8/02 ,  C21D8/04 ,  C21D9/48 ,  C21D2211/005 ,  C22C38/04 ,  C22C38/06 ,  C22C38/12 ,  C22C38/14 ,  Y10T29/49108

摘要： A cold-rolled steel sheet has a composition containing, by mass percent, 0.0040% or less of C, 0.02% or less of Si, 0.14% to 0.25% of Mn, 0.020% or less of P, 0.015% or less of S, 0.0040% or less of N, 0.020% to 0.070% of Al, 0.005% to 0.030% of Nb, 0.005% to 0.030% of Ti, (0.0003% to 0.0010% of the equivalent amount of solid solution B (from which the amount of B forming BN has been subtracted)), and the balance composed of Fe and inevitable impurities, wherein even when the rolling reduction of cold rolling is 85% or less, the average grain size of a ferrite structure is reliably 12.0 μm or less, and the relationship −0.20≦Δr≦0.20 can be reliably satisfied and which has an excellent earing property.

摘要翻译： 冷轧钢板的组成为：以质量％计含有C：0.02％以下，Si：0.14〜0.25％，P：0.020％以下，S：0.015％以下，0.0040％ ，0.0040％以下的N，0.020〜0.070％的Al，0.005〜0.030％的Nb，0.005〜0.030％的Ti，（0.0003〜0.0010％的固溶B的当量） 已经减去了形成BN的B量）），余量由Fe和不可避免的杂质构成，即使在冷轧的压下率为85％以下的情况下，铁素体组织的平均粒径也可靠地为12.0μm以下 ，并且可以可靠地满足-0.20＆nlE;＆Dgr; r＆nlE; 0.20的关系，具有优异的耳朵特性。

公开(公告)号：US20090025838A1

公开(公告)日：2009-01-29

申请号：US12282538

申请日：2007-03-13

申请人： Nobuko Mineji ,  Eiko Yasuhara ,  Reiko Sugihara ,  Tadashi Inoue

发明人： Nobuko Mineji ,  Eiko Yasuhara ,  Reiko Sugihara ,  Tadashi Inoue

IPC分类号： C21D8/04 ,  C22C38/00 ,  H01M2/02

CPC分类号： B21B1/22 ,  B21B3/00 ,  C21D8/02 ,  C21D8/04 ,  C21D9/48 ,  C21D2211/005 ,  C22C38/04 ,  C22C38/06 ,  C22C38/12 ,  C22C38/14 ,  Y10T29/49108

摘要： A cold-rolled steel sheet has a composition containing, by mass percent, 0.0040% or less of C, 0.02% or less of Si, 0.14% to 0.25% of Mn, 0.020% or less of P, 0.015% or less of S, 0.0040% or less of N, 0.020% to 0.070% of Al, 0.005% to 0.030% of Nb, 0.005% to 0.030% of Ti, (0.0003% to 0.0010% of the equivalent amount of solid solution B (from which the amount of B forming BN has been subtracted)), and the balance composed of Fe and inevitable impurities, wherein even when the rolling reduction of cold rolling is 85% or less, the average grain size of a ferrite structure is reliably 12.0 μm or less, and the relationship −0.20≦Δr≦0.20 can be reliably satisfied and which has an excellent earing property.

摘要翻译： 冷轧钢板的组成为：以质量％计含有C：0.02％以下，Si：0.14〜0.25％，P：0.020％以下，S：0.015％以下，0.0040％ ，0.0040％以下的N，0.020〜0.070％的Al，0.005〜0.030％的Nb，0.005〜0.030％的Ti，（0.0003〜0.0010％的固溶B的当量） 已经减去形成BN的B量）），余量由Fe和不可避免的杂质构成，即使在冷轧的压下率为85％以下的情况下，铁素体组织的平均粒径可靠地为12.0μm以下 ，并且可以可靠地满足关系-0.20 <= Deltar <= 0.20，具有优异的耳朵特性。

公开(公告)号：US20090300902A1

公开(公告)日：2009-12-10

申请号：US12519539

申请日：2006-12-20

申请人： Nobuko Mineji ,  Reiko Sugihara ,  Tadashi Inoue

发明人： Nobuko Mineji ,  Reiko Sugihara ,  Tadashi Inoue

IPC分类号： H01M6/00 ,  C21D8/04 ,  C22C38/04

CPC分类号： C21D9/46 ,  C22C38/004 ,  C22C38/04 ,  Y10T29/49108

摘要： A cold-rolled steel sheet that is suitable for battery cases and has low anisotropy is composed of, by mass %, C: ≦0.0030%, Si: ≦0.02%, Mn: 0.15 to 0.19%, P: ≦0.020%, S: ≦0.015%, N: ≦0.0040%, Al: 0.020 to 0.070%, Nb: 1.00≦Nb/C (atomic equivalent ratio)≦5.0, B: 1 ppm≦B-(11/14)N≦15 ppm (in the expression, B and N denote the contents of the respective elements), and the balance: being Fe and inevitable impurities, and has a planar anisotropy Δr of the r-value in the range of −0.10≦Δr≦0.10. In a process for producing the steel sheet, the cold rolling is performed at a rolling ratio of 70 to 87%, and then annealing is performed on a continuous annealing line at an annealing temperature of from the recrystallization temperature to 830° C.

摘要翻译： 适用于电池壳体并且各向异性低的冷轧钢板以质量％计含有C：<= 0.0030％，Si：<= 0.02％，Mn：0.15〜0.19％，P：<0.020 ％，S：<= 0.015％，N：<= 0.0040％，Al：0.020〜0.070％，Nb：1.00 <= Nb / C（原子当量比）<= 5.0，B：1ppm <= B- / 14）N <= 15ppm（在表达式中，B和N表示各元素的含量），余量为Fe和不可避免的杂质，并且在r值范围内具有平面各向异性Deltar -0.10 <= Deltar <= 0.10。 在钢板的制造方法中，以轧制率为70〜87％进行冷轧，然后在从再结晶温度至830℃的退火温度下在连续退火生产线上进行退火。

公开(公告)号：US09765511B2

公开(公告)日：2017-09-19

申请号：US12937629

申请日：2009-12-07

申请人： Tadashi Inoue ,  Hisao Nakajima

发明人： Tadashi Inoue ,  Hisao Nakajima

IPC分类号： E04B1/19 ,  E04B1/18 ,  E04B1/08 ,  E04B1/61 ,  E04B1/24

CPC分类号： E04B1/18 ,  E04B1/08 ,  E04B1/6141 ,  E04B2001/2481 ,  E04B2001/2487

摘要： A framing member forming a frame of a factory building is provided with a slit for attaching a holder on one side face of the framing member, the slit extending in a longitudinal direction of the framing member, the slit is provided with a detachment prevention mechanism configured to exert an action of preventing an insertion piece of the holder from being detached and to fix the holder to the framing member, along with an insertion of the insertion piece into the slit, and the holder is provided with a pinching piece configured to pinch an end edge portion of a wall panel between the pinching piece and the framing member to fix the wall panel to the framing member, along with the insertion of the insertion piece into the slit.

公开(公告)号：US09051296B2

公开(公告)日：2015-06-09

申请号：US13509442

申请日：2010-11-16

申请人： Tatsuya Yamagishi ,  Yoshimasa Arano ,  Mikio Morita ,  Tadashi Inoue

发明人： Tatsuya Yamagishi ,  Yoshimasa Arano ,  Mikio Morita ,  Tadashi Inoue

IPC分类号： A61K31/435 ,  A01N43/40 ,  C07D221/04 ,  C07D401/06 ,  A61K31/44 ,  A61K31/445 ,  A61K31/4525 ,  A61K31/4535 ,  A61K31/454 ,  A61K31/4545 ,  A61K31/4709 ,  A61K31/4725 ,  A61K31/4745 ,  A61K31/498 ,  A61K31/4985 ,  A61K31/506 ,  A61K31/519 ,  A61K31/5383 ,  C07D211/46 ,  C07D401/10 ,  C07D401/12 ,  C07D401/14 ,  C07D405/06 ,  C07D405/12 ,  C07D405/14 ,  C07D409/06 ,  C07D413/06 ,  C07D417/06 ,  C07D417/10 ,  C07D455/04 ,  C07D471/04 ,  C07D471/06 ,  C07D487/04 ,  C07D491/048 ,  C07D495/04 ,  C07D498/04 ,  C07D513/04

CPC分类号： C07D401/06 ,  A61K31/435 ,  A61K31/44 ,  A61K31/445 ,  A61K31/4525 ,  A61K31/4535 ,  A61K31/454 ,  A61K31/4545 ,  A61K31/4709 ,  A61K31/4725 ,  A61K31/4745 ,  A61K31/498 ,  A61K31/4985 ,  A61K31/506 ,  A61K31/519 ,  A61K31/5383 ,  C07D211/46 ,  C07D401/10 ,  C07D401/12 ,  C07D401/14 ,  C07D405/06 ,  C07D405/12 ,  C07D405/14 ,  C07D409/06 ,  C07D413/06 ,  C07D417/06 ,  C07D417/10 ,  C07D455/04 ,  C07D471/04 ,  C07D471/06 ,  C07D487/04 ,  C07D491/048 ,  C07D495/04 ,  C07D498/04 ,  C07D513/04

摘要： The present invention relates to aryl carboxamide derivatives of formula (I), wherein Ar1 is phenyl; Ar2 is aryl; n is 1-4; X is —O—, —S—, —SO— or —SO2—, a prodrug thereof or a pharmaceutically acceptable salt thereof, which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of such disorders and diseases as pain in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases as pain in which voltage gated sodium channels are involved.

摘要翻译： 本发明涉及式（I）的芳基甲酰胺衍生物，其中Ar 1是苯基; Ar2是芳基; n为1-4; X是-O - ， - S-，-SO-或-SO 2 - ，其前药或其药学上可接受的盐，其具有作为TTX-S通道的电压门控钠通道的阻断活性，并且其可用于 治疗或预防这种疾病和疾病，如涉及电压门控钠通道的疼痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗诸如涉及电压门控钠通道的疼痛的疾病中的用途。

公开(公告)号：US20100025471A1

公开(公告)日：2010-02-04

申请号：US12508168

申请日：2009-07-23

申请人： Satoshi Nakazawa ,  Tadashi Inoue

发明人： Satoshi Nakazawa ,  Tadashi Inoue

IPC分类号： G06K7/10

CPC分类号： G06K7/10831

摘要： A barcode reading apparatus include a barcode reader for reading a barcode, a moving mechanism for defining a movement position of the barcode reader in a plane, an angle adjusting mechanism for adjusting a reading angle of the barcode reader in a direction orthogonal to a longitude direction of the barcode, a controller for controlling the moving mechanism upon reading the barcode to adjust a position of the barcode reader to a barcode reading position, and controlling the angle adjusting mechanism in the adjusted position to adjust the reading angle of the barcode reader.

摘要翻译： 条形码读取装置包括：条形码读取器，用于读取条形码;移动机构，用于定义条形码读取器在平面中的移动位置;角度调整机构，用于在与经度方向正交的方向上调整条形码读取器的读取角度; 条形码读取器，用于在读取条形码时控制移动机构，以便将条形码读取器的位置调整到条形码读取位置，并且控制在调整位置的角度调节机构来调节条形码读取器的读取角度。

公开(公告)号：US07622589B2

公开(公告)日：2009-11-24

申请号：US11384127

申请日：2006-03-17

申请人： Takeshi Hanazawa ,  Misato Hirano ,  Tadashi Inoue ,  Satoshi Nagayama ,  Kazunari Nakao ,  Yuji Shishido ,  Hirotaka Tanaka

发明人： Takeshi Hanazawa ,  Misato Hirano ,  Tadashi Inoue ,  Satoshi Nagayama ,  Kazunari Nakao ,  Yuji Shishido ,  Hirotaka Tanaka

IPC分类号： C07D213/02 ,  A61K31/44 ,  A61K31/445

CPC分类号： C07C61/28 ,  C07C61/40 ,  C07C311/08 ,  C07C317/44 ,  C07C323/62 ,  C07C2601/02 ,  C07D213/26 ,  C07D213/56 ,  C07D213/74 ,  C07D213/76

摘要： This invention provides a compound of the formula (I): wherein, variables A, B, D, E, and R1 to R11 are as defined in the specification.

摘要翻译： 本发明提供式（I）的化合物：其中变量A，B，D，E和R 1至R 11如说明书中所定义。

公开(公告)号：US20060100460A1

公开(公告)日：2006-05-11

申请号：US11270780

申请日：2005-11-09

申请人： Tadashi Inoue ,  Satoshi Nagayama ,  Kazunari Nakao

发明人： Tadashi Inoue ,  Satoshi Nagayama ,  Kazunari Nakao

IPC分类号： C07D211/26 ,  A61K31/445 ,  A61K31/18 ,  C07C311/19

CPC分类号： C07C311/08 ,  C07C2601/02 ,  C07C2602/08 ,  C07C2602/10 ,  C07D295/096 ,  C07D311/16

摘要： This invention provides a compound of the formula (I): wherein R1 represents a (C1-C6)alkyl group; R2 represents a hydrogen atom, a halogen atom, a hydroxy group, a (C1-C6) alkyl group or a (C1-C6) alkoxy group; R3, R4, R5 and R6 each independently represents a hydrogen atom, a (C1-C6) alkyl, or a halogen atom; R7 represents a hydrogen atom, a halogen atom, a hydroxy group, a (C1-C6) alkyl group optionally substituted with a piperidino group, a (C-1-C6)alkoxy group optionally substituted with a 3-7 membered cycloalkyl ring, a hydroxy(C1-C6)alkoxy group, a (C1-C6)alkoxy-(C1-C6)alkyl group, a (C1-C6)alkoxy-(C1-C6)alkoxy group, a halo (C1-C6)alkyl group, a (C1-C6)alkylthio group, a (C1-C6)alkylsulfinyl group or a (C1-C6)alkylsulfonyl group; R5 represents a (C1-C6)alkyl group, a halo(C1-C6)alkyl group, a (C1-C6)alkoxy group, a hydroxy(C1-C6)alkoxy group, a (C1-C6)alkoxy-(C1-C6)alkyl group or a (C1-C6)alkoxy-(C1-C6)alkoxy group; or R7 and R8, when adjacent to each other, taken together with the carbon atoms to which they are attached form a 5-8 membered carbocyclic or heterocyclic ring, wherein the carbocyclic ring or the heterocyclic ring is unsubstituted or substituted with one or more substituents selected from the group consisting of a hydroxy group, a (C1-C6)alkyl group, a (C1-C6)alkoxy group and a hydroxy(C1-C6)alkyl group; and R9 represents a hydrogen atom or a halogen atom; or a pharmaceutically acceptable salt or solvate thereof. These compounds are useful for the treatment of disease conditions caused by overactivation of VR1 receptor, such as pain or the like in mammalian. The present invention also provides a pharmaceutical composition comprising the compound of formula (I).

公开(公告)号：US06623573B2

公开(公告)日：2003-09-23

申请号：US09838017

申请日：2001-04-19

申请人： Tadashi Inoue ,  Yoichi Motoyashiki ,  Hiroyasu Kikuchi ,  Sadanori Imada

发明人： Tadashi Inoue ,  Yoichi Motoyashiki ,  Hiroyasu Kikuchi ,  Sadanori Imada

IPC分类号： C21D800

CPC分类号： C21D8/0226 ,  C21D8/021

摘要： The method for manufacturing steel sheet comprises the steps of: forming a sheet bar; forming a steel strip; primary-cooling; air-cooling; secondary-cooling; and coiling. The sheet bar is finish-rolled at finish temperatures of (Ar3 transformation point −20° C.) or more. The primary cooling cools the finish-rolled steel strip at cooling speeds of more than 120° C./sec down to the temperatures ranging from 500 to 800° C.

摘要翻译： 制造钢板的方法包括以下步骤：形成板坯; 形成钢带; 一次冷却; 空冷; 二次冷却 和卷取。 片材在（Ar3相变点-20℃）以上的最终温度下进行精轧。 主冷却冷却速度高于120℃/秒的冷轧钢带至500至800℃的温度。